Resources
About Us
Home Report
Store
Protein Assays Market
Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital) – Global Forecast to 2031
Report ID:MRHC - 1041120 Pages: 220 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Protein Assays Market was valued at $2.14 billion in 2023. This market is expected to reach $4.36 billion by 2031, from an estimated $2.34 billion in 2024, at a CAGR of 9.3% during the forecast period 2024-2031.
Protein Assays Market Size & Forecast
Protein assays are used for the measurement of protein in samples or biological fluids with the use of detergents, dyes, or reagents. The purpose of the assay is protein quantification—that is, to determine the concentration or amount of an array of proteins or specific proteins. There are different types of protein assays on the basis of their sensitivity and specificity, including Bradford Protein Assay, Bicinchoninic Acid (BCA) Assay, Lowry Protein Assay, and others. Protein assays vary in their chemical basis for detecting protein-specific functional groups. Some assay methods detect peptide bonds, but no assay does this exclusively.
The growth of this market can be attributed to various factors, such as the increasing pharmaceutical R&D expenditures, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth.
Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are major challenges for the market’s growth.
Increasing Demand for Protein Assays in the Pharmaceutical & Biotechnology Industry
The global pharmaceutical industry is experiencing rapid growth. This growth is attributed to various factors, such as patent expirations, the introduction of new drugs, improved accessibility to medicines in remote areas, and high investments in R&D. For instance, in 2022, the investments and funding by venture capitalists in biotech and pharma companies in the U.S. increased to USD 30.7 billion from USD 18.7 billion in 2019 (Source: National Venture Capital Association). Additionally, in 2021, Pharmaceutical Research and Manufacturers of America (PhRMA) member companies invested USD 102.3 billion in research and development (Source: 2022 PhRMA member annual survey).
Protein assays are used for the quantification of protein in a given sample. The assays are also used to standardize the results of pharmaceutical preparation obtained from another method. Pharmaceutical companies increasingly prefer protein assays as they do not require any hazardous reagents, obtain faster results, and are easy to perform at room temperature.
In the biotechnology industry, protein assays are one of the most widely used scientific methods. Protein assays are used for the determination of protein concentration in the sample, which is necessary for protein purification, molecular biology, cell biology, and other research applications.
Rising Use of Protein Assays in Clinical Diagnostic Tests
Chronic diseases pose a significant burden across many countries. According to the United Health Foundations (U.S.), in 2022, 29.3 million adults, representing 11.2% of the population, reported having three or more chronic conditions. In 2020, the global prevalence of chronic diseases was estimated at 57%. According to the International Diabetes Federation, globally, the number of people with diabetes aged 20–79 reached 537 million in 2021, increasing from 425 million in 2017. This number is projected to reach 643 million by 2030.
The rising prevalence of chronic diseases is increasing the need to develop novel therapies for the treatment of chronic diseases. Protein assays are used in the laboratories to determine the protein concentration of biological samples, which then can be further processed by other technologies. The rise in the prevalence of chronic diseases is increasing the adoption of protein assays in diagnostic & pathology laboratories as the determination of protein quantitation is a prerequisite for many of the molecular diagnostic tests for early disease diagnosis, thereby driving the market.
Click here to: Get Free Sample Pages of this Report
Key Findings in the Global Protein Assays Market Study:
Among all the Offerings, in 2024, the Reagents & Kits Segment is Expected to Account for the Largest Share of the Market
Based on offering, the protein assays market is segmented into reagents & kits and instruments & accessories. In 2024, the reagents & kits segment is expected to account for the largest share of the market. Continuous advancements in terms of the development of reagents and kits, high adoption and recurring consumption of protein assay kits, and wide availability of consumables support the segment’s large share. The increasing adoption of protein assays in clinical diagnostics due to rising disease prevalence is further contributing to the market growth.
Among all the Types, in 2024, the Dye-based Assay Segment is Expected to Account for the Largest Share of the Market
Based on type, the global protein assays market is segmented into dye-based assay, copper-based assay, and other assay types. In 2024, the dye-based assay segment is expected to account for the largest share of the market. The large market share of this segment is attributed to its higher preference for simplicity, speed, and sensitivity. Dye-based assays enable accurate and quick quantification of protein quantification, owing to which these assays are widely used in clinical diagnostics and research applications.
Among all the Technologies, in 2024, the Absorbance-based Protein Assay Segment is Expected to Account for the Largest Share of the Market
Based on technology, the protein assays market is segmented into fluorescence-based protein assay, absorbance-based protein assay, and colorimetric-based protein assay. In 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. Absorbance is the simplest detection method that offers simplicity and broad applicability. Absorbance assays are applied to a wide variety of samples, making them ideal to use in research applications. Absorbance assays are non-destructive and can be used for subsequent analysis. These factors support the largest share of absorbance-based assays in the market.
In 2024, the Drug Discovery Segment is Expected to Account for the Largest Share of the Market
Based on application, the global protein assays market is segmented into research & development, drug discovery, clinical diagnosis, label claims, and other applications. In 2024, the drug discovery segment is expected to account for the largest share of the market. The large market share of this segment is attributed to increased spending on pharmaceutical R&D, the need to develop new therapies owing to increasing disease prevalence, and supportive initiatives for drug research. An increase in pharmaceutical research initiatives drives the adoption of protein assays. Protein assays facilitate an understanding of disease biology and enable the development, production, and quality assurance of protein-based therapeutics, owing to which their demand is higher in pharmaceutical R&D for drug discovery & development.
Among all the End Users, in 2024, the Pharmaceutical & Biotechnology Companies Segment is Expected to Account for the Largest Share of the Market
Based on end users, the protein assays market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, food & beverage companies, and other end users. In 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the significant investments in research and development (R&D) activities and infrastructure development by pharmaceutical & biotechnology companies. The funding for research laboratories is increasing due to the rising demand for new drugs and therapies, which is driving the demand for protein assays. For instance, global pharmaceutical R&D expenditure is expected to reach USD 213 billion in 2026 from USD 179 billion in 2020 (Source: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)).
North America: Largest Regional Market
In 2024, North America is expected to account for the largest share of the protein assays market. North America's significant market share is attributed to several factors, including substantial R&D investments by pharmaceutical and biotechnology companies for drug and biomarker development, growing prevalence of chronic diseases, increased healthcare expenditure, the presence of key market players in the region, and favorable government initiatives supporting research and development. For instance, according to the U.S. Department of Health & Human Services, in 2022, the National Institute of Health (NIH) allocated USD 45 billion for biomedical research. The surge in R&D spending by pharmaceutical companies is anticipated to drive the demand for protein assays, which are crucial for qualitative and quantitative protein testing in the pharmaceutical sector.
Protein Assays Market: Competitive Analysis
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years. The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).
Protein Assays Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
~220 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
9.3% |
|
Estimated Market Size (Value) |
$4.36 billion by 2031 |
|
Segments Covered |
By Offering
By Type
By Technology
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America (Brazil, Mexico, RoLATAM), and Middle East & Africa |
|
Key Companies |
Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.). |
Key questions answered in the report:
The global protein assays market covers the study of different types of protein assays used in protein quantification in clinical diagnostics and research applications. This report involves the analysis of various segments of protein assays at the regional and country levels.
The global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% during the forecast period.
In 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. The largest market share is attributed to the increasing use of dye-based protein assays in the estimation of protein concertation, the use of these assays in disease diagnosis, and the faster process of performing the assay.
In 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. The largest market share is attributed to the absorbance-based protein assays being the simplest detection method preferred by research and clinical laboratories.
The growth of this market can be attributed to various factors, such as increasing pharmaceutical R&D expenditures, rising use of protein assay in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests.
Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities.
The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).
Emerging countries in Asia-Pacific are projected to offer significant growth opportunities for vendors in this market due to their advancing healthcare infrastructure, increasing number of research and clinical laboratories, and rising research funding in the healthcare and pharmaceutical industry.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Pharmaceutical R&D Expenditure
4.2.2. Increasing Use of Protein Assay in Drug Discovery & Development
4.2.3. Growth in Food & Beverage Industry
4.2.4. Rising Use of Protein Assays in Clinical Diagnostic Tests
4.3. Restraint
4.3.1. High Cost of Protein Quantification Devices
4.4. Opportunities
4.4.1. Increasing Focus on Proteomics Research
4.4.2 Use of Protein Assays in Personalized Medicines
4.5. Challenges
4.5.1. High Chances of Error With Complex Samples
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s 5 Force Analysis
5. Protein Assays Market Assessment—by Offering
5.1. Overview
5.2. Reagents & Kits
5.3. Instruments & Accessories
6. Protein Assays Market Assessment—by Type
6.1. Overview
6.2. Dye-based Assay
6.3. Copper-based Assay
6.4. Other Assay Types
7. Protein Assays Market Assessment—by Technology
7.1. Overview
7.2. Fluorescence-based Protein Assays
7.3. Absorbance-based Protein Assays
7.4. Colorimetric-based Protein Assays
8. Protein Assays Market Assessment—by Application
8.1. Overview
8.2. Drug Discovery
8.3. Research & Development
8.4. Clinical Diagnosis
8.5. Label Claims
8.6. Other Applications
9. Protein Assays Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Food & Beverage Companies
9.5. Other End Users
10. Protein Assays Market Assessment–by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America (RoLATAM)
10.6. Middle East and Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Ranking, by Key Players (2023)
12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. Bio-Rad Laboratories, Inc.
12.2. Thermo Fisher Scientific Inc.
12.3. Revvity, Inc.
12.4. Merck KGaA
12.5. Abcam plc
12.6. F. Hoffmann-La Roche AG
12.7. Danaher Corporation
12.8. Promega Corporation
12.9. Cell Signaling Technology, Inc.
12.10. Agilent Technologies, Inc.
12.11. Novus Biologicals
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 2 Global Protein Assays Reagents & Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Protein Assays Instruments & Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 5 Global Dye-based Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Copper-based Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Protein Assays Market for Other Types, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 9 Global Fluroscence-based Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Absorbance-based Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Colorimetric Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 13 Global Protein Assays Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Protein Assays Market for Research & Development, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Protein Assays Market for Clinical Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Protein Assays Market for Label Claims, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Protein Assays Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 19 Global Protein Assays Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Protein Assays Market for Hospital & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Protein Assays Market for Food & Beverage Companies, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Protein Assays Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Protein Assays Market, by Country/Region, 2021-2030 (USD Million)
Table 24 North America: Protein Assays Market, by Country, 2022–2031 (USD Million)
Table 25 North America: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 26 North America: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 27 North America: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 28 North America: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 29 North America: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 30 U.S.: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 31 U.S.: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 32 U.S.: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 33 U.S.: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 34 U.S.: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 35 Canada: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 36 Canada: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 37 Canada: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 38 Canada: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 39 Canada: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 40 Europe: Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 41 Europe: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 42 Europe: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 43 Europe: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 44 Europe: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 45 Europe: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 46 Germany: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 47 Germany: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 48 Germany: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 49 Germany: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 50 Germany: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 51 France: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 52 France: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 53 France: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 54 France: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 55 France: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 56 U.K.: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 57 U.K.: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 58 U.K.: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 59 U.K.: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 60 U.K.: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 61 Italy: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 62 Italy: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 63 Italy: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 64 Italy: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 65 Italy: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 66 Spain: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 67 Spain: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 68 Spain: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 69 Spain: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 70 Spain: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 71 Rest of Europe: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 72 Rest of Europe: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 73 Rest of Europe: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 74 Rest of Europe: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 75 Rest of Europe: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 76 Asia-Pacific: Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 77 Asia-Pacific: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 78 Asia-Pacific: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 79 Asia-Pacific: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 80 Asia-Pacific: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 81 Asia-Pacific: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 82 China: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 83 China: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 84 China: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 85 China: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 86 China: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 87 Japan: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 88 Japan: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 89 Japan: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 90 Japan: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 91 Japan: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 92 India: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 93 India: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 94 India: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 95 India: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 96 India: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 97 Rest of Asia-Pacific: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 98 Rest of Asia-Pacific: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 99 Rest of Asia-Pacific: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 100 Rest of Asia-Pacific: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 101 Rest of Asia-Pacific: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 102 Latin America: Protein Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 103 Latin America: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 104 Latin America: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 105 Latin America: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 106 Latin America: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 107 Latin America: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 108 Brazil: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 109 Brazil: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 110 Brazil: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 111 Brazil: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 112 Brazil: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 113 Mexico: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 114 Mexico: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 115 Mexico: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 116 Mexico: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 117 Mexico: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 118 Rest of Latin America: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 119 Rest of Latin America: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 120 Rest of Latin America: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 121 Rest of Latin America: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 122 Rest of Latin America: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 123 Middle East and Africa: Protein Assays Market, by Offering, 2022–2031 (USD Million)
Table 124 Middle East and Africa: Protein Assays Market, by Type, 2022–2031 (USD Million)
Table 125 Middle East and Africa: Protein Assays Market, by Technology, 2022–2031 (USD Million)
Table 126 Middle East and Africa: Protein Assays Market, by Application, 2022–2031 (USD Million)
Table 127 Middle East and Africa: Protein Assays Market, by End User, 2022–2031 (USD Million)
Table 128 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Protein Assays Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 8 Global Protein Assays Market, by Type, 2024 VS. 2031 (USD Million)
Figure 9 Global Protein Assays Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 10 Global Protein Assays Market, by Application, 2024 VS. 2031 (USD Million)
Figure 11 Global Protein Assays Market, by End User, 2024 VS. 2031 (USD Million)
Figure 12 Protein Assays Market, by Geography
Figure 13 Global Protein Assays Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 14 Global Protein Assays Market, by Type, 2024 VS. 2031 (USD Million)
Figure 15 Global Protein Assays Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 16 Global Protein Assays Market, by Application, 2024 VS. 2031 (USD Million)
Figure 17 Global Protein Assays Market, by End User, 2024 VS. 2031 (USD Million)
Figure 18 Global Protein Assays Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 19 North America: Protein Assays Market Snapshot
Figure 20 Europe: Protein Assays Market Snapshot
Figure 21 Asia-Pacific: Protein Assays Market Snapshot
Figure 22 Latin America: Protein Assays Market Snapshot
Figure 23 Key Growth Strategies Adopted by Leading Players, 2020—2024
Figure 24 Global Protein Assays Market: Competitive Dashboard
Figure 25 Global Protein Assays Market: Competitive Benchmarking, by Type
Figure 26 Global Protein Assays Market: Market Share Analysis/Market Ranking (2023)
Figure 27 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 28 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 29 Reevity, Inc.: Financial Snapshot (2023)
Figure 30 Merck KGaA: Financial Snapshot (2023)
Figure 31 Abcam plc: Financial Snapshot (2022)
Figure 32 F. Hoffmann-La Roche AG: Financial Snapshot (2023)
Figure 33 Danaher Corporation: Financial Snapshot (2023)
Figure 34 Agilent Technologies, Inc.: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
IVD Assay Development Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Oct-2024
Multiplex Assays Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jul-2024
Protein Expression Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Lateral Flow Assays Market - Global Opportunity Analysis And Industry Forecast (2020-2027)
Published Date: Jun-2021
Molecular Cytogenetics Market - Global Opportunity Analysis and Industry Forecast (2017-2022)
Published Date: Aug-2017
